Effects of Non-invasive Vagus Nerve Stimulation on Inflammatory Markers in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amira Mohamed Taha • Amr Elrosasy • Ahmed S. Mohamed •et.al. DOI: 10.7759/cureus.70613  Abstract The international healthcare community has encountered several difficulties because of the COVID-19 pandemic brought on by SARS-CoV-2. COVID-19 can lead to an…[...]

Read More

Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone

Abdel-Hameed W. Al-Mistarehi • Shadi El-Akawi • Khalid A. Kheirallah,  et. al.DOI: 10.7759/cureus.67467  Abstract Background: Several medications have been proposed to manage COVID-19, with controversial data regarding their clinical benefits. We aimed to investigate the clinical…[...]

Read More

Dynamics of SARS-CoV-2 Immunoglobulin G Antibody Among Hospitalized Patients and Healthcare Workers During the Delta Wave in Bangladesh

Md. Abdul Matin • Chowdhury Adnan Sami • Md. Ashraful Hassan Anjan • et. al DOI: 10.7759/cureus.82175 Peer-Reviewed Abstract Background: A reliable marker of COVID-19 past infection is the anti-spike IgG antibody (Ab) titer of the SARS-CoV-2 virus, which…[...]

Read More

Incidence of Neurological Manifestations in Critically Ill COVID-19 Patients

Sasa Dragic • Andrea Dolencuk • Danica Momcicevic • et. al., DOI: 10.7759/cureus.85616  Abstract Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not primarily a neurotropic virus. However, since angiotensin-converting enzyme 2 (ACE2) receptors are present…[...]

Read More